$VRTX VERTEX PHARMACEUTICALS INC / MA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA. Insider overview, share value development, latest insider transactions and email notifications about new events in VERTEX PHARMACEUTICALS INC / MA for free.
IRS Number: 043039129
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: VRTX
Company Address: 50 NORTHERN AVENUE BOSTON 02210
Phone number: (617) 444-6100
Market Capitalization: $21.78B
Prev close: $86.84
Average Daily Volume: 1,946,100
Days Low: $85.79
Year Low: $71.46
Year High: $103.73
VERTEX PHARMACEUTICALS INC / MA Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 05 2021 | VRTX | VERTEX PHARMACEUTI ... | WAGNER CHARLES F JR | EVP & Chief Financi ... | Payment of Exercise | F | 217.21 | 547 | 118,814 | 34,679 | 35.2 K to 34.7 K (-1.55 %) |
| May 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sanna Bastiano | EVP, Cell & Genetic ... | Sell | S | 218.83 | 459 | 100,443 | 34,108 | 34.6 K to 34.1 K (-1.33 %) |
| May 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sanna Bastiano | EVP, Cell & Genetic ... | Sell | S | 218.06 | 501 | 109,248 | 34,567 | 35.1 K to 34.6 K (-1.43 %) |
| May 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sanna Bastiano | EVP, Cell & Genetic ... | Payment of Exercise | F | 217.21 | 766 | 166,383 | 35,068 | 35.8 K to 35.1 K (-2.14 %) |
| May 04 2021 | VRTX | VERTEX PHARMACEUTI ... | MCKENZIE DIANA | Director | Grant | A | 0.00 | 1,842 | 0 | 3,277 | 1.4 K to 3.3 K (+128.36 %) |
| May 04 2021 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 217.20 | 3,034 | 658,985 | 3,034 | |
| May 04 2021 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 921 | 0 | 1,798 | 877 to 1.8 K (+105.02 %) |
| May 04 2021 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | A | 217.20 | 6,067 | 1,317,752 | 6,067 | |
| May 04 2021 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | A | 217.20 | 6,067 | 1,317,752 | 6,067 | |
| May 04 2021 | VRTX | VERTEX PHARMACEUTI ... | Garber Alan M | Director | Option Exercise | A | 217.20 | 6,067 | 1,317,752 | 6,067 | |
| May 04 2021 | VRTX | VERTEX PHARMACEUTI ... | CARNEY LLOYD | Director | Grant | A | 0.00 | 1,842 | 0 | 5,401 | 3.6 K to 5.4 K (+51.76 %) |
| Apr 29 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 86.52 | 3,884 | 336,044 | 0 | |
| Apr 29 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 217.69 | 200 | 43,538 | 40,133 | 40.3 K to 40.1 K (-0.50 %) |
| Apr 29 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 216.67 | 1,338 | 289,904 | 40,333 | 41.7 K to 40.3 K (-3.21 %) |
| Apr 29 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 215.58 | 2,346 | 505,751 | 41,671 | 44 K to 41.7 K (-5.33 %) |
View all VERTEX PHARMACEUTICALS INC / MA insider transactions.